Recent Activities
AI creates Podcasts!
Who I Am
I am Co-Founder & CTO at Erudio Bio, Inc. and Co-Founder & CEO at Erudio Bio Korea, Inc. where we’re pioneering AI-driven biomarker discovery and drug development, serve as a KFAS-Salzburg Global Leadership Initiative Fellow and a Member of AI-Korean Medicine Integration Initiative Task Force for the Association of Korean Medicine, and hold positions as Adjunct Professor at Sogang University and Advisory Professor at DGIST.
I’m also Leader of the Silicon Valley Privacy Preserving AI Forum (K-PAI)—a role that has unexpectedly become one of the defining aspects of my career. Through K-PAI, I’ve become widely recognized throughout Silicon Valley’s Korean community for building this vibrant community of AI professionals, researchers, entrepreneurs, investors, journalists, and industry leaders.
The K-PAI phenomenon has been one of the most unexpected turns in my career. What began in November 2024 as a forum for privacy-preserving AI has grown into a movement—hosting 10+ major events (within a year!), attracting hundreds of attendees, partnering with K-BioX, KOTRA Silicon Valley, K•ASIC, and creating a vibrant community that has fundamentally changed how I’m known in Silicon Valley. Today, when people in the South Bay Korean tech community think “AI”, they think “K-PAI”.
My journey has taken me from Convex Optimization at Stanford University, semiconductor optimization & Machine Learning (ML) at Samsung, through e-commerce innovation via Artificial Intelligent (AI) at Amazon (where one project generated $200M in revenue), to co-founding Gauss Labs and serving as CTO—an industrial AI company—and now to the frontier of AI-powered biotechnology. I hold a Ph.D. in Electrical Engineering from Stanford University, where I studied under Prof. Stephen P. Boyd, the world’s leading authority on Convex Optimization.
What drives me is connecting the dots between seemingly disparate fields. My background spans the theoretical depth of mathematics and convex optimization, the practical demands of engineering and AI development, and the philosophical questions of how technology shapes society. This interdisciplinary perspective allows me to see patterns others might miss—whether in technology trends, market dynamics, or the broader societal implications of AI advancement.
(For a complete professional biography, please visit my About page.)
Some of My Press Exposures
- 에루디오바이오, 게이츠재단 지원금 기반 신약개발혁신 플랫폼 만든다 – 아시아경제 @ 30-Oct-2025 KST
현재 신약 개발의 90% 이상이 임상시험에서 실패한다. 약물과 인체의 상호작용이 너무 복잡해 초기 단계에서 충분히 검증하지 못하기 때문이다. 에루디오바이오의 bioTCAD는 동적 힘 분광법으로 측정한 고품질 분자 상호작용 데이터를 활용해, 동물실험 단계인 전임상에서 신약 설계를 더욱 신뢰할 수 있고 빠르게 만든다. 의약품 개발 비용을 낮추고 개발 기간을 단축함으로써 새로운 저비용치료법을 절실히 필요로 하는 저소득 및 중소득 국가(LMICs)가 혜택을 받을 수 있다.
한편 에루디오바이오는 지난 7월 한국 법인 에루디오바이오코리아를 설립해 서울대학교 분당병원과 암 바이오마커 검출 제품 공동 개발을 추진하고 있다. 한국인 특화 암 진단 솔루션 개발을 목표로 기관생명윤리위원회(IRB) 승인 절차가 진행 중이며, 연내 승인 완료를 목표로 하고 있다. 이 기술은 기존 다중화 진단의 핵심 한계인 교차반응성과 위양성 문제를 해결해 암 조기 진단의 정확도를 크게 높일 수 있을 것으로 기대된다. 내년 상반기 첫 임상 데이터를 확보하고, 2027년 상반기 식품의약품안전처에 의료기기 허가를 신청할 예정이다.
- Riverside the Ground Up Podcast - Holistic Landscape of Biotechnology + AI recorded @ 08-Oct-2025 PDT
- 어디서도 못 사는 K데이터…반도체·의료산업 차별성 살려라 – 머니투데이 @ 20-Oct-2025 KST
- 고려대학교 CDTB, ‘인공지능 시대의 진화와 통찰’ 주제로 DTB 세미나 개최 – 고려대학교 경영대학원 CDTB @ 27-Oct-2025 KST
- 윤성희 자문교수, SK의 AI 승부수 “가우스랩스” R&D 최고책임자로 – 대구경북과학기술대학교 @ 23-Sep-2020 KST
- 최태원의 승부수… SK그룹, 美 실리콘밸리서 AI 자회사 출범 – Chosun Biz @ 22-Sep-2020 KST
- SK, ‘산업 AI 솔루션’ 사업 진출… AI 전문기업 ‘가우스랩스’ 설립 – 오피니언뉴스 @ 22-Sep-2020 KST
- 가우스랩스 출범 10개월… ‘올해 말까지 현재 2배 규모 AI 인재 채용’ – AI라이프경제 @ 30-Jun-2021 KST
- “반도체와 함께 Industrial AI 분야 Top Tier가 되겠습니다” - SK그룹의 첫 AI 전문 기업 ‘가우스랩스’를 가다 – SK hynix Newsroom @ 29-Jun-2021 KST
- AI 강조한 SK 최태원, 600억원 투자 반도체 제조혁신 ‘정조준’ – Financial Economic TV @ 22-Sep-2020 KST
(For more of my press exposures, please refer to Press Exposures section.)
Leadership Roles
Founder & Leader of K-PAI!
The K-PAI Phenomenon
What started as a vision has grown into one of the most unexpected and transformative chapters of my career. As Founder and Leader of Silicon Valley Privacy-preserving AI Forum (K-PAI), I’ve built a thriving community that has made me a household name among Korean professionals throughout Silicon Valley’s South Bay. Today, nearly every Korean in the South Bay (tech) community knows me as “the K-PAI person”—a recognition that reflects the Forum’s remarkable impact and reach.
Erudio Bio - Co-Founder & CTO / Erudio Bio Korea - Co-Founder & CEO
At Erudio Bio, we’re pioneering the next generation of drug discovery and precision medicine through AI-powered biomarker platforms. Our mission is to transform how we understand disease, identify therapeutic targets, and develop treatments—accelerating the path from biological insight to patient impact.
The Vision - AI-Driven Biological Intelligence
The pharmaceutical industry faces a fundamental challenge: despite massive investments, drug development remains slow, expensive, and failure-prone. Most drug candidates fail in late-stage trials because we don’t fully understand the biological mechanisms of disease. Erudio Bio is changing this paradigm by building AI systems that can integrate and reason across the entire landscape of biological knowledge—from genomics and proteomics to clinical data and scientific literature.
Recent Milestones
Gates Foundation Grant (2025) We were awarded a Prestigious Grant from the Gates Foundation to advance our AI-driven biomarker platforms for global health challenges. This recognition validates our approach and extends our impact beyond commercial drug development to addressing diseases that disproportionately affect underserved populations.
Versatile Smart Assay (VSA) Platform Our patented VSA technology represents a breakthrough in biomarker detection, enabling rapid, accurate, and cost-effective analysis of multiple biomarkers simultaneously. We developed this technology in partnership with world-class institutions:
- Stanford Medicine - Translational research and innovation
- Harvard Medical School - Clinical validation and medical expertise
- Analog Devices - Semiconductor and signal processing technology
Strategic & Technical Partnerships
We’re building an ecosystem of world-class partners across academia, healthcare, and industry:
Clinical & Research Partnerships
- Seoul National University Bundang Hospital (SNUBH): Joint development of integrated biochip medical device for cancer diagnosis and monitoring using our VSA platform for multiple biomarker detection—a collaboration that brings our AI-driven insights directly into clinical practice
- Institut Pasteur Korea: Infectious disease research and drug discovery
- Na-Eun Hospital: Clinical applications and validation
Technology & Industry Partners
- Lulumedic: Bio data platform integration, combining their data infrastructure with our AI analytics
- Korea Research Institute of Bioscience and Biotechnology (KRIBB): Advanced bioscience research
- National Nanofab Center: Nanofabrication and micro/nano device development
This partnership network spans the US and Korea, connecting Silicon Valley innovation with Korean clinical excellence and manufacturing capabilities.
What Makes Erudio Bio Different
We’re also uniquely positioned at the intersection of:
- Silicon Valley AI innovation and biotech/pharma domain expertise
- Cutting-edge Machine Learning (ML) and Artificial Intelligence (AI) and rigorous biological validation
- Academic research excellence and commercial product development
- US and Korean markets with operations in both countries
KFAS-Salzburg Global Leadership Initiative Fellow
December 2024 - Present
As a KFAS-Salzburg Global Leadership Initiative Fellow, I’m part of an international cohort addressing the theme “Uncertain Futures and Connections Reimagined: Connecting Technologies.”
Our group focuses on “Technology, Growth, and Inequality: The Case of AI” — examining how artificial intelligence is simultaneously driving economic growth and potentially widening societal inequalities. We’re developing actionable policy recommendations for how nations can harness AI’s benefits while ensuring equitable access and mitigating risks.
Key Activities:
- Co-authoring policy reports on AI fairness, digital ethics, and equitable access
- Engaging with global leaders, policymakers, and researchers across the US, Europe, and Asia-Pacific
- Developing frameworks for responsible AI deployment in critical sectors including healthcare, finance, and education
- Bridging perspectives between Silicon Valley innovation culture and global regulatory approaches
Read our group’s report: Technology, Growth, and Inequality: The Case of AI
Please read my related blog post: Bridging Technology and Humanity - Reflections from Lyon, Salzburg, and München
What Makes My Perspective Unique
My approach to AI and technology is grounded in unusual depth across multiple dimensions:
Mathematical Foundations I studied under one of few living legends in optimization theory (and the only legend throughout the human history in Convex Optimization), giving me rare insight into the mathematical structures that underpin modern AI. This theoretical grounding enables me to understand not just how AI systems work, but why they work—and more importantly, when they won’t. (Please refer to the blog posts about (pure) math that I’ve written here for better understanding!)
Cross-Industry Experience From semiconductor manufacturing to e-commerce to biotech, I’ve seen how AI transforms different industries. This breadth reveals patterns in technology adoption, implementation challenges, and business value creation that are invisible when viewing a single sector. (Please refer to my blog posts related to these topics such as this or this or this!)
Technology-Humanities Bridge While deeply technical, I’m equally engaged with philosophy, history, cognitive science, and social sciences. This allows me to think about AI not just as a technology problem but as a societal transformation—considering questions of consciousness, ethics, economic equity, and human flourishing alongside technical architecture and algorithmic efficiency. (Please refer to some of my blog posts or articles related to these topics such as this or this or this or this or this!)
Entrepreneurial & Strategic Lens Having co-founded companies and advised Fortune 500 executives, I understand the full spectrum from breakthrough research to market realization, from technical feasibility to business viability, from product development to strategic positioning. (Please refer to my special lectures on various topics of AI and Convex Optimization and consultations for executives of Fortune 500 companies here!)
Community Builder & Connector Through founding and leading K-PAI, I’ve demonstrated the ability to build thriving communities that bridge disciplines, cultures, and institutions. This community-building expertise—connecting people, ideas, and opportunities—has become one of my most impactful contributions to Silicon Valley’s tech ecosystem. (You can see everything, I mean everything about K-PAI here, including, but not limited to, all the forum announcements, reflections, blog posts, partnership, K-PAI membership, and K-PAI committee!)
This convergence of mathematical rigor, engineering expertise, cross-industry experience, and humanistic perspective allows me to offer insights that bridge the gap between technical possibility and human necessity—between what AI can do and what it should do, but more importantly, how and what we should do!
Recent and Near Future Major Activities
(Note that a (close to) exhaustive list of my seminars, special AI lectures, corporate consultations, etc. can be found here!)
December 2025
AI-BioX ConfEX Grand Summit
Seoul, South Korea | December 11-13, 2025 KST
A global symposium on AI and bio innovation, bringing together leaders from biotechnology, AI research, and pharmaceutical industries to explore the convergence of artificial intelligence and life sciences.
My Role: Speaker and VIP panelist discussing AI-driven drug discovery and biomarker platforms
November 2025
Becoming the Leader of AI Era
San Jose, CA | November 15, 2025 PST
A community talk for the Korean-American community exploring “From ChatGPT to Your Future Superpower” — how today’s generation can harness AI as a tool for building, discovering, and creating, with insights drawn from my experience in global tech, biotech, and academia.
- Location Educational Park Branch Library, San Jose, CA, USA
- Topic How AI is transforming medicine, science, and creativity—and what it means for future careers and opportunities
IFEZ X K-BioX ABDD Summit
Song-do, South Korea | November 7, 2025 KST
AI Biohealthcare Drug Discovery Summit, bringing together leaders in pharmaceutical innovation, biotech entrepreneurship, and AI-driven drug development to discuss the future of precision medicine.
My Role Speaker and VIP presenting on AI biotech innovations and Erudio Bio’s approach to biomarker discovery & AI Landscape seen in Silicon Valley as Leader of Silicon Valley Privacy-preserving AI Forum (K-PAI)
October 2025
KUBS CDTB Special AI Lecture
Korean University Business School (KUBS) - Center for Digital Transformation & Business (CDTB) | October 24, 2025 KST
Invited lecture on “The Economics of Intelligence - How AI is Reshaping Business Models, Markets, and Competitive Advantage” — exploring the future of agentic AI systems and their applications across industries.
ICTC 2025 AI Seminar
International Conference on ICT Convergence | October 15, 2025 KST
Keynote on “Convergent AI Innovation - From Protein Folding Breakthroughs to Agentic AI for Sustainable Future” — examining how AI is revolutionizing both biological research and industrial applications.
KICSV Special AI Lectures
Korea Innovation Center (KIC) Silicon Valley | October 6, 2025 PDT
Two-part lecture series:
September 2025
G-Quantum Bio Summit 2025
Suwon, South Korea | September 22-24, 2025 KST
A summit convening Korean-American scientists and engineers with Korean biotech leaders to foster collaboration between Silicon Valley innovation and Korean pharmaceutical and biotech industries.
My Role Global VIP / Mentor / Speaker presenting on AI-powered biotech platforms and Erudio Bio’s mission
Two key sessions:
- G-Bio Week Keynote: “From Silicon Valley to Biotech Valley: AI Agents Reshaping the Future of Drug Discovery and Precision Medicine”
- G-BIVA Innovation Salon: “Intelligent Agents, Intelligent Medicine: AI’s Role in Next-Gen Healthcare”
SNU ECS Four-Departments Joint Seminar
Seoul National University | September 18, 2025 KST
“AI Pulse Check: What Silicon Valley Is Actually Building Right Now” — providing real-time insights from the epicenter of AI development to Korea’s top engineering students and faculty.
KUBS Special AI Lecture
Korea University Business School | September 18, 2025 KST
“The AI Revolution: How Smart Systems Are Reshaping Industries and Executive Decision-Making” — exploring AI’s impact on business strategy, competitive advantage, and organizational transformation.
POSTECH Convergence IT Engineering AI Seminar
POSTECH | September 17, 2025 KST
“The Complete AI Landscape: Where We Are, Where We’re Going” — a comprehensive overview of the current state and future trajectory of artificial intelligence across all domains.
August 2025
K-PAI Forum - The Human-Centric AI Revolution
Stanford University | August 20, 2025 PDT
A landmark K-PAI forum held at Stanford’s EVGR Theater featuring Natalie Huh on AI regulatory insights and James Rhee on “Agency in a New World Order: AI and Humanism in Musical Counterpoint.” This forum brought together legal, philosophical, and technical perspectives on building AI that serves humanity.
June 2025
KFAS 2025 - AI & Humanity
Seoul, South Korea | June 27, 2025 KST
Watch the Presentation & Watch the Interview
Knowledge Festival All Seasons (KFAS) 2025 keynote presentation on “The AI Metamorphosis: Navigating New Frontiers in Technology, Society, and Human Experience” — exploring the philosophical, societal, and ethical dimensions of AI transformation. (program book)
2025 KAIST BBE Bay Area Research Exchange
Stanford University | June 22, 2025 PDT
A symposium co-organized by KAIST Bio & Brain Engineering (BBE), Korea Innovation Center, KOLIS, and Stanford K-BioX to foster collaboration between Korean and Bay Area biotech researchers.
My Role Panelist in the “Global Biotech Innovation Ecosystem” discussion, sharing insights on building successful biotech ventures and bridging academic research with commercial applications
Looking Forward
The convergence of AI with biotechnology, the evolution of privacy-preserving technologies, and the urgent need for ethical AI governance present both opportunities and responsibilities. Through my work at Erudio Bio, K-PAI, and as a Salzburg Fellow, I’m committed to ensuring that as AI systems become more powerful, they serve humanity’s long-term flourishing—advancing health, preserving liberty, promoting equality, and ultimately enabling genuine human happiness.
K-PAI will continue to grow as Silicon Valley’s premier forum for responsible AI innovation, bringing together the brightest minds to tackle the most pressing challenges at the intersection of AI, privacy, security, and human values. We’re not just discussing the future—we’re actively building it, one conversation, one connection, one breakthrough at a time.
My goal isn’t just to build better technology, but to build better futures—futures where technological advancement and human values aren’t in tension but in harmony.